Gynaecological diseases are common in India because of socio-economic conditions, hygiene literacy problems. Women health is one of most neglected issues in developing countries like India. With the increasing awareness, the ow of patients visiting gynaecology outpatient department (OPD) has increased. Gynaecological drugs are one of the strong selling drugs in pharmaceutical market. Drug utilization research facilitate appropriate use of drugs in patient, minimize the adverse event and lead to better patient outcome. This study revisits the utilization patterns of drugs used in the gynaecology OPD. A prospective, observational and cross-sectional study was conducted in Department of Pharmacology in collaboration with Department of Obstetrics and Gynaecology of tertiary healthcare hospital. Total 360 prescriptions were analysed, most of them belonged to the age group of 31-50 years. The Average number of drugs per prescription is 3.2. 38.33% were found to be infective while 61.66% were non-infective. Total 1876 drugs were prescribed. Among all drugs, Hematopoietic agents were most commonly prescribed (46.69%) followed by antimicrobials (29.16%). 98.40% drugs were prescribed by generic name and by 1.60% brand name. 91.95% drugs prescribed were included in WHO essential drugs list 2021. 96.69% drugs prescribed were included in National list of essential medicines (NLEM) 2015. In this study it was observed that majority of patients visiting the OPD were from urban areas, as the women from rural areas depend on peripheral health services, so it is crucial to strengthen the peripheral health services, to reduce the mortality and morbidity amongst the population.

Background: The Cardiovascular disease is emerging as one of the leading cause of morbidity and mortality worldwide. To determine the appropriateness of the prescriptions and various trends in treatment, so as to provide the basis for modification in the future drug usage in accordance with risk factors and clinical presentations and also assess the improvement of health-related quality of life of patients with coronary artery disease. Methods: A prospective, observational and cross-sectional study was conducted in Department of Pharmacology in collaboration with Department of Medicine of tertiary healthcare hospital. As per inclusion criteria, patients visiting Medicine Outpatient department (OPD) from November 2021 to January 2022 were enrolled in the study. Results: Total 360 prescriptions were analysed, most of them belonged to the age group of 61-75 years. The prevalence was higher in Females (54%) than males (46%). An average number of drugs per prescription was 4.5. All the drugs were prescribed by generic names. 90.63% drugs prescribed were included in World Health Organization (WHO) essential drugs list 2021. 98.40% drugs prescribed were included in National list of essential medicines (NLEM) 2015. Antiplatelets (99.44%) were the most commonly prescribed category of drugs, followed by hyperlipidaemic (96.67%). Conclusion: The overall analysis of prescription pattern suggests that most of the drugs were prescribed rationally according to current American College of Cardiology Federation/American Heart Association (ACC/ AHA) guidelines. The incidence of polypharmacy was in the normal limits as per WHO recommendation. Generic drugs were prescribed majorly, which promotes awareness amongst prescribers, supporting WHO policies.